"","pathway","pval","padj","overlap","size","overlapGenes","sample_id"
"1","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.229711506492936,1,1,214,"ENSG00000182670","MM909_02"
"2","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.494579524505083,1,1,558,"ENSG00000149591","MM909_02"
"3","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_02"
"4","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_02"
"5","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_02"
"6","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_02"
"7","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_02"
"8","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_02"
"9","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_02"
"10","GCM_PSME1",1,1,0,83,"","MM909_02"
"11","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_02"
"12","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_02"
"13","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_02"
"14","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_02"
"15","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_02"
"16","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_02"
"17","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_02"
"18","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_02"
"19","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_02"
"20","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_02"
"21","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_02"
"22","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_02"
"23","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_02"
"24","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_02"
"25","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_02"
"26","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_02"
"27","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_02"
"28","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_02"
"29","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_02"
"30","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_02"
"31","KEGG_PROTEASOME",1,1,0,44,"","MM909_02"
"32","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_02"
"33","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_02"
"34","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_02"
"35","MORF_PSMC1",1,1,0,189,"","MM909_02"
"36","MORF_PSMC2",1,1,0,115,"","MM909_02"
"37","MORF_PSMF1",1,1,0,166,"","MM909_02"
"38","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_02"
"39","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_02"
"40","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_02"
"41","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_02"
"42","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_02"
"43","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_02"
"44","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_02"
"45","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_02"
"46","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_02"
"47","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_02"
"48","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_02"
"49","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_02"
"50","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_02"
"51","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_02"
"52","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_02"
"53","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_02"
"54","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_02"
"55","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_02"
"56","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_02"
"57","MORF_PSMF1",0.00362636591372172,0.115634433635217,7,166,"ENSG00000012232, ENSG00000009413, ENSG00000159216, ENSG00000100095, ENSG00000114923, ENSG00000064313, ENSG00000119685","MM909_03"
"58","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.00412980120125774,0.115634433635217,7,170,"ENSG00000241484, ENSG00000112186, ENSG00000103381, ENSG00000088387, ENSG00000100297, ENSG00000182621, ENSG00000101310","MM909_03"
"59","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.00696059038128232,0.117471918609111,8,235,"ENSG00000058668, ENSG00000112186, ENSG00000083857, ENSG00000108010, ENSG00000137261, ENSG00000214107, ENSG00000065833, ENSG00000108671","MM909_03"
"60","GOBP_PROTEASOME_ASSEMBLY",0.00839085132922222,0.117471918609111,2,12,"ENSG00000136813, ENSG00000108671","MM909_03"
"61","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",0.0147908622209097,0.141738456848202,2,16,"ENSG00000115414, ENSG00000159216","MM909_03"
"62","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.015186263233736,0.141738456848202,6,169,"ENSG00000144452, ENSG00000162433, ENSG00000163618, ENSG00000134853, ENSG00000139970, ENSG00000111490","MM909_03"
"63","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",0.0271863613235691,0.189601958548623,2,22,"ENSG00000175899, ENSG00000134853","MM909_03"
"64","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.0296630924534358,0.189601958548623,8,307,"ENSG00000177479, ENSG00000138411, ENSG00000138641, ENSG00000109790, ENSG00000133606, ENSG00000049759, ENSG00000185345, ENSG00000108671","MM909_03"
"65","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.0304717433381716,0.189601958548623,4,100,"ENSG00000116748, ENSG00000039537, ENSG00000069020, ENSG00000100095","MM909_03"
"66","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.0666380484145096,0.27750960907963,2,36,"ENSG00000134817, ENSG00000115592","MM909_03"
"67","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.0674181795761544,0.27750960907963,11,558,"ENSG00000183044, ENSG00000241484, ENSG00000132437, ENSG00000088387, ENSG00000130764, ENSG00000106355, ENSG00000100297, ENSG00000176953, ENSG00000182621, ENSG00000239306, ENSG00000134308","MM909_03"
"68","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.0701767755900289,0.27750960907963,3,81,"ENSG00000163823, ENSG00000150995, ENSG00000137462","MM909_03"
"69","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.0721007649900812,0.27750960907963,4,133,"ENSG00000138641, ENSG00000049759, ENSG00000185345, ENSG00000126261","MM909_03"
"70","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.0727203091051525,0.27750960907963,7,308,"ENSG00000122218, ENSG00000198033, ENSG00000126261, ENSG00000124486, ENSG00000028116, ENSG00000134308, ENSG00000171467","MM909_03"
"71","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",0.0792884597370371,0.27750960907963,1,7,"ENSG00000108671","MM909_03"
"72","LE_SKI_TARGETS_DN",0.0792884597370371,0.27750960907963,1,7,"ENSG00000115380","MM909_03"
"73","GOCC_PROTEASOME_COMPLEX",0.152391720220197,0.501996254843003,2,59,"ENSG00000136813, ENSG00000108671","MM909_03"
"74","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",0.191391314691547,0.562464035917328,1,18,"ENSG00000175899","MM909_03"
"75","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.194161377546537,0.562464035917328,2,69,"ENSG00000136928, ENSG00000184939","MM909_03"
"76","GOCC_PROTEASOME_REGULATORY_PARTICLE",0.200880012827617,0.562464035917328,1,19,"ENSG00000108671","MM909_03"
"77","GOCC_PROTEASOME_ACCESSORY_COMPLEX",0.237735746733389,0.587945721799616,1,23,"ENSG00000108671","MM909_03"
"78","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",0.237735746733389,0.587945721799616,1,23,"ENSG00000197172","MM909_03"
"79","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.2414777071677,0.587945721799616,2,80,"ENSG00000128052, ENSG00000141027","MM909_03"
"80","TIEN_INTESTINE_PROBIOTICS_2HR_UP",0.298195438981023,0.695789357622387,1,30,"ENSG00000242515","MM909_03"
"81","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",0.330568405472692,0.74047322825883,1,34,"ENSG00000197172","MM909_03"
"82","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",0.353865583420256,0.762172025828243,1,37,"ENSG00000134853","MM909_03"
"83","KEGG_PARKINSONS_DISEASE",0.383005871339849,0.794382547964131,2,113,"ENSG00000185345, ENSG00000169021","MM909_03"
"84","KEGG_PROTEASOME",0.405125137571545,0.81025027514309,1,44,"ENSG00000108671","MM909_03"
"85","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",0.432571523275801,0.819901949250459,1,48,"ENSG00000136381","MM909_03"
"86","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",0.43923318709846,0.819901949250459,1,49,"ENSG00000108671","MM909_03"
"87","TIEN_INTESTINE_PROBIOTICS_6HR_UP",0.458753191427465,0.828715442578647,1,52,"ENSG00000242515","MM909_03"
"88","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",0.501701437452877,0.861301236507518,1,59,"ENSG00000108671","MM909_03"
"89","WP_PROTEASOME_DEGRADATION",0.507552514370502,0.861301236507518,1,60,"ENSG00000108671","MM909_03"
"90","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",0.524697267715627,0.864207264472798,1,63,"ENSG00000122218","MM909_03"
"91","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.650406560543619,1,1,89,"ENSG00000241484","MM909_03"
"92","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.717179120771638,1,2,214,"ENSG00000141027, ENSG00000242515","MM909_03"
"93","WONG_MITOCHONDRIA_GENE_MODULE",0.719566875441727,1,2,215,"ENSG00000148834, ENSG00000169021","MM909_03"
"94","MORF_PSMC2",0.742900211504706,1,1,115,"ENSG00000144048","MM909_03"
"95","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.819681695252356,1,1,145,"ENSG00000186462","MM909_03"
"96","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_03"
"97","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_03"
"98","GCM_PSME1",1,1,0,83,"","MM909_03"
"99","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_03"
"100","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_03"
"101","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_03"
"102","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_03"
"103","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_03"
"104","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_03"
"105","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_03"
"106","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_03"
"107","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_03"
"108","MORF_PSMC1",1,1,0,189,"","MM909_03"
"109","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_03"
"110","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_03"
"111","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_03"
"112","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_03"
"113","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",0.0177434128177454,0.993631117793742,1,37,"ENSG00000117114","MM909_06"
"114","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.0678098835783477,1,1,145,"ENSG00000116701","MM909_06"
"115","MORF_PSMF1",0.0772539996430577,1,1,166,"ENSG00000115194","MM909_06"
"116","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.079042350410789,1,1,170,"ENSG00000114019","MM909_06"
"117","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_06"
"118","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_06"
"119","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_06"
"120","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_06"
"121","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_06"
"122","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_06"
"123","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_06"
"124","GCM_PSME1",1,1,0,83,"","MM909_06"
"125","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_06"
"126","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_06"
"127","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_06"
"128","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_06"
"129","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_06"
"130","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_06"
"131","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_06"
"132","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_06"
"133","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_06"
"134","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_06"
"135","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_06"
"136","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_06"
"137","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_06"
"138","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_06"
"139","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_06"
"140","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_06"
"141","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_06"
"142","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_06"
"143","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_06"
"144","KEGG_PROTEASOME",1,1,0,44,"","MM909_06"
"145","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_06"
"146","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_06"
"147","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_06"
"148","MORF_PSMC1",1,1,0,189,"","MM909_06"
"149","MORF_PSMC2",1,1,0,115,"","MM909_06"
"150","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_06"
"151","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_06"
"152","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_06"
"153","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_06"
"154","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_06"
"155","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_06"
"156","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_06"
"157","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_06"
"158","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_06"
"159","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_06"
"160","TIEN_INTESTINE_PROBIOTICS_24HR_UP",1,1,0,558,"","MM909_06"
"161","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_06"
"162","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_06"
"163","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_06"
"164","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_06"
"165","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_06"
"166","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_06"
"167","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_06"
"168","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_06"
"169","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",0.027838410491081,1,1,16,"ENSG00000155093","MM909_11"
"170","MORF_PSMF1",0.254174435383005,1,1,166,"ENSG00000186866","MM909_11"
"171","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.339914901319468,1,1,235,"ENSG00000137261","MM909_11"
"172","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.420003338612013,1,1,308,"ENSG00000198033","MM909_11"
"173","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.627986537754803,1,1,558,"ENSG00000133131","MM909_11"
"174","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_11"
"175","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_11"
"176","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_11"
"177","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_11"
"178","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_11"
"179","GCM_PSME1",1,1,0,83,"","MM909_11"
"180","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_11"
"181","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_11"
"182","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_11"
"183","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_11"
"184","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_11"
"185","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_11"
"186","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_11"
"187","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_11"
"188","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_11"
"189","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_11"
"190","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_11"
"191","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_11"
"192","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_11"
"193","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_11"
"194","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_11"
"195","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_11"
"196","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_11"
"197","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_11"
"198","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_11"
"199","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_11"
"200","KEGG_PROTEASOME",1,1,0,44,"","MM909_11"
"201","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_11"
"202","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_11"
"203","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_11"
"204","MORF_PSMC1",1,1,0,189,"","MM909_11"
"205","MORF_PSMC2",1,1,0,115,"","MM909_11"
"206","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_11"
"207","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_11"
"208","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_11"
"209","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_11"
"210","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_11"
"211","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_11"
"212","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_11"
"213","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_11"
"214","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_11"
"215","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_11"
"216","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_11"
"217","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_11"
"218","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_11"
"219","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_11"
"220","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_11"
"221","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_11"
"222","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_11"
"223","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_11"
"224","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_11"
"225","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",0.00740086653144945,0.414448525761169,1,34,"ENSG00000154175","MM909_14"
"226","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.0312099612520369,0.873878915057033,1,145,"ENSG00000150347","MM909_14"
"227","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.065213176518749,1,1,308,"ENSG00000117523","MM909_14"
"228","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_14"
"229","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_14"
"230","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_14"
"231","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_14"
"232","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_14"
"233","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_14"
"234","GCM_PSME1",1,1,0,83,"","MM909_14"
"235","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_14"
"236","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_14"
"237","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_14"
"238","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_14"
"239","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_14"
"240","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_14"
"241","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_14"
"242","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_14"
"243","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_14"
"244","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_14"
"245","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_14"
"246","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_14"
"247","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_14"
"248","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_14"
"249","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_14"
"250","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_14"
"251","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_14"
"252","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_14"
"253","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_14"
"254","KEGG_PROTEASOME",1,1,0,44,"","MM909_14"
"255","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_14"
"256","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_14"
"257","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_14"
"258","MORF_PSMC1",1,1,0,189,"","MM909_14"
"259","MORF_PSMC2",1,1,0,115,"","MM909_14"
"260","MORF_PSMF1",1,1,0,166,"","MM909_14"
"261","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_14"
"262","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_14"
"263","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_14"
"264","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_14"
"265","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_14"
"266","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_14"
"267","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_14"
"268","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_14"
"269","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_14"
"270","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_14"
"271","TIEN_INTESTINE_PROBIOTICS_24HR_UP",1,1,0,558,"","MM909_14"
"272","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_14"
"273","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_14"
"274","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_14"
"275","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_14"
"276","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_14"
"277","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_14"
"278","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_14"
"279","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_14"
"280","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_14"
"281","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.00141179442920764,0.0539211116478214,6,307,"ENSG00000044090, ENSG00000103657, ENSG00000154359, ENSG00000125826, ENSG00000172009, ENSG00000182247","MM909_15"
"282","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.00192575398742219,0.0539211116478214,4,133,"ENSG00000158290, ENSG00000044090, ENSG00000103657, ENSG00000182247","MM909_15"
"283","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.00454546966819463,0.0848487671396332,4,169,"ENSG00000119866, ENSG00000173114, ENSG00000139970, ENSG00000005379","MM909_15"
"284","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.0072544363747143,0.101562109246,3,100,"ENSG00000147889, ENSG00000188037, ENSG00000005108","MM909_15"
"285","MORF_PSMC2",0.0106136487782152,0.118872866316011,3,115,"ENSG00000095139, ENSG00000128524, ENSG00000101146","MM909_15"
"286","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",0.0608503963320902,0.567937032432842,1,16,"ENSG00000119866","MM909_15"
"287","TIEN_INTESTINE_PROBIOTICS_2HR_UP",0.111060680771394,0.888485446171149,1,30,"ENSG00000162337","MM909_15"
"288","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",0.171707228525026,1,1,48,"ENSG00000105676","MM909_15"
"289","WONG_PROTEASOME_GENE_MODULE",0.171707228525026,1,1,48,"ENSG00000103194","MM909_15"
"290","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",0.209830539301473,1,1,60,"ENSG00000101680","MM909_15"
"291","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.234792309265418,1,2,235,"ENSG00000151320, ENSG00000131711","MM909_15"
"292","MORF_PSMF1",0.479055888605798,1,1,166,"ENSG00000236104","MM909_15"
"293","MORF_PSMC1",0.524124605380301,1,1,189,"ENSG00000101146","MM909_15"
"294","WONG_MITOCHONDRIA_GENE_MODULE",0.570411655479572,1,1,215,"ENSG00000128524","MM909_15"
"295","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.702187557703925,1,1,308,"ENSG00000150760","MM909_15"
"296","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_15"
"297","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_15"
"298","GCM_PSME1",1,1,0,83,"","MM909_15"
"299","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_15"
"300","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_15"
"301","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_15"
"302","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_15"
"303","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_15"
"304","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_15"
"305","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_15"
"306","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_15"
"307","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_15"
"308","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_15"
"309","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_15"
"310","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_15"
"311","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_15"
"312","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_15"
"313","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_15"
"314","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_15"
"315","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_15"
"316","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_15"
"317","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_15"
"318","KEGG_PROTEASOME",1,1,0,44,"","MM909_15"
"319","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_15"
"320","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_15"
"321","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_15"
"322","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_15"
"323","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_15"
"324","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_15"
"325","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_15"
"326","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_15"
"327","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_15"
"328","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_15"
"329","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_15"
"330","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_15"
"331","TIEN_INTESTINE_PROBIOTICS_24HR_UP",1,1,0,558,"","MM909_15"
"332","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_15"
"333","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_15"
"334","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_15"
"335","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_15"
"336","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_15"
"337","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.000115024195744794,0.00644135496170849,4,81,"ENSG00000124207, ENSG00000150995, ENSG00000147526, ENSG00000187555","MM909_16"
"338","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.00184200647779757,0.0515761813783319,4,169,"ENSG00000073464, ENSG00000048052, ENSG00000103546, ENSG00000149256","MM909_16"
"339","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.00307365027918977,0.0573748052115424,2,27,"ENSG00000136068, ENSG00000078114","MM909_16"
"340","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",0.00571685914470685,0.0800360280258959,2,37,"ENSG00000117114, ENSG00000115641","MM909_16"
"341","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.0303261964181608,0.339653399883401,2,89,"ENSG00000073464, ENSG00000196700","MM909_16"
"342","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.0623735343782987,0.546847305414186,2,133,"ENSG00000078043, ENSG00000144744","MM909_16"
"343","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.0683559131767732,0.546847305414186,3,308,"ENSG00000076003, ENSG00000117523, ENSG00000198176","MM909_16"
"344","MORF_PSMF1",0.0912894008256562,0.591238669576867,2,166,"ENSG00000078043, ENSG00000114923","MM909_16"
"345","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.0950205004677107,0.591238669576867,2,170,"ENSG00000115641, ENSG00000196700","MM909_16"
"346","WONG_PROTEASOME_GENE_MODULE",0.136095933912576,0.651539173838937,1,48,"ENSG00000144744","MM909_16"
"347","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.138580141899777,0.651539173838937,2,214,"ENSG00000140563, ENSG00000125676","MM909_16"
"348","WONG_MITOCHONDRIA_GENE_MODULE",0.139615537251201,0.651539173838937,2,215,"ENSG00000016391, ENSG00000115616","MM909_16"
"349","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",0.164591640056764,0.709010141782985,1,59,"ENSG00000111087","MM909_16"
"350","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.189684424534626,0.758737698138504,1,69,"ENSG00000131408","MM909_16"
"351","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.241626464332164,0.902072133506745,3,558,"ENSG00000138399, ENSG00000076003, ENSG00000187555","MM909_16"
"352","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.511920915628079,1,1,235,"ENSG00000116977","MM909_16"
"353","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.608421238946227,1,1,307,"ENSG00000144744","MM909_16"
"354","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_16"
"355","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_16"
"356","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_16"
"357","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_16"
"358","GCM_PSME1",1,1,0,83,"","MM909_16"
"359","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_16"
"360","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_16"
"361","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_16"
"362","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_16"
"363","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_16"
"364","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_16"
"365","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_16"
"366","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_16"
"367","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_16"
"368","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_16"
"369","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_16"
"370","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_16"
"371","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_16"
"372","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_16"
"373","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_16"
"374","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_16"
"375","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_16"
"376","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_16"
"377","KEGG_PROTEASOME",1,1,0,44,"","MM909_16"
"378","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_16"
"379","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_16"
"380","MORF_PSMC1",1,1,0,189,"","MM909_16"
"381","MORF_PSMC2",1,1,0,115,"","MM909_16"
"382","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_16"
"383","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_16"
"384","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_16"
"385","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_16"
"386","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_16"
"387","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_16"
"388","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_16"
"389","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_16"
"390","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_16"
"391","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_16"
"392","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_16"
"393","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",0.00172511616410076,0.0966065051896427,2,23,"ENSG00000143119, ENSG00000184678","MM909_17"
"394","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.00703642626806644,0.19701993550586,3,145,"ENSG00000115165, ENSG00000148516, ENSG00000185947","MM909_17"
"395","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.0147639661428237,0.275594034666043,2,69,"ENSG00000184678, ENSG00000130821","MM909_17"
"396","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.0295262157442834,0.395812407378482,2,100,"ENSG00000003400, ENSG00000188037","MM909_17"
"397","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",0.0418433673774821,0.395812407378482,1,16,"ENSG00000115414","MM909_17"
"398","LE_SKI_TARGETS_UP",0.0444000066462529,0.395812407378482,1,17,"ENSG00000157168","MM909_17"
"399","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.0494765509223102,0.395812407378482,2,133,"ENSG00000114423, ENSG00000175104","MM909_17"
"400","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.0695963214014975,0.466875687689628,1,27,"ENSG00000157168","MM909_17"
"401","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.075256402812493,0.466875687689628,2,169,"ENSG00000137642, ENSG00000005379","MM909_17"
"402","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",0.0868396702376474,0.466875687689628,1,34,"ENSG00000184678","MM909_17"
"403","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.0917077243676054,0.466875687689628,1,36,"ENSG00000168959","MM909_17"
"404","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",0.120378969313041,0.558857018818503,1,48,"ENSG00000163832","MM909_17"
"405","TIEN_INTESTINE_PROBIOTICS_6HR_UP",0.129734665082867,0.558857018818503,1,52,"ENSG00000137642","MM909_17"
"406","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",0.154955832947438,0.619823331789752,1,63,"ENSG00000109501","MM909_17"
"407","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.192511930961625,0.654730133733298,1,80,"ENSG00000127603","MM909_17"
"408","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.194668696757845,0.654730133733298,1,81,"ENSG00000175104","MM909_17"
"409","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.19875736202618,0.654730133733298,2,308,"ENSG00000120805, ENSG00000168610","MM909_17"
"410","MORF_PSMC2",0.264688055571687,0.823473950667472,1,115,"ENSG00000182220","MM909_17"
"411","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.435935868874328,1,1,214,"ENSG00000130821","MM909_17"
"412","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.466810959097432,1,1,235,"ENSG00000163788","MM909_17"
"413","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.560457519953738,1,1,307,"ENSG00000114423","MM909_17"
"414","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.776209558811456,1,1,558,"ENSG00000068383","MM909_17"
"415","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_17"
"416","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_17"
"417","GCM_PSME1",1,1,0,83,"","MM909_17"
"418","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_17"
"419","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_17"
"420","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_17"
"421","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_17"
"422","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_17"
"423","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_17"
"424","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_17"
"425","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_17"
"426","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_17"
"427","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_17"
"428","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_17"
"429","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_17"
"430","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_17"
"431","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_17"
"432","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_17"
"433","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_17"
"434","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_17"
"435","KEGG_PROTEASOME",1,1,0,44,"","MM909_17"
"436","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_17"
"437","MORF_PSMC1",1,1,0,189,"","MM909_17"
"438","MORF_PSMF1",1,1,0,166,"","MM909_17"
"439","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_17"
"440","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_17"
"441","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_17"
"442","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_17"
"443","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_17"
"444","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_17"
"445","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_17"
"446","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_17"
"447","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_17"
"448","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_17"
"449","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.00847963296504427,0.194419798546289,2,36,"ENSG00000134817, ENSG00000185338","MM909_20"
"450","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.0148453695350188,0.194419798546289,3,133,"ENSG00000012048, ENSG00000109670, ENSG00000185338","MM909_20"
"451","TIEN_INTESTINE_PROBIOTICS_6HR_UP",0.0171455437752193,0.194419798546289,2,52,"ENSG00000125691, ENSG00000137642","MM909_20"
"452","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.0186422108965862,0.194419798546289,3,145,"ENSG00000186462, ENSG00000082641, ENSG00000129116","MM909_20"
"453","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",0.0228068992188487,0.194419798546289,1,6,"ENSG00000072274","MM909_20"
"454","MORF_PSMF1",0.0264630845150365,0.194419798546289,3,166,"ENSG00000012048, ENSG00000140459, ENSG00000162896","MM909_20"
"455","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.0277027015788629,0.194419798546289,3,169,"ENSG00000137642, ENSG00000072274, ENSG00000005379","MM909_20"
"456","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.0290747037853939,0.194419798546289,2,69,"ENSG00000173068, ENSG00000168386","MM909_20"
"457","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.0312460390520821,0.194419798546289,4,307,"ENSG00000109670, ENSG00000157450, ENSG00000185338, ENSG00000024048","MM909_20"
"458","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.0568151471919569,0.267512619144266,2,100,"ENSG00000166743, ENSG00000188037","MM909_20"
"459","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",0.0596728901588851,0.267512619144266,1,16,"ENSG00000100985","MM909_20"
"460","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.062478621454961,0.267512619144266,3,235,"ENSG00000168386, ENSG00000070495, ENSG00000129116","MM909_20"
"461","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",0.0668781547860665,0.267512619144266,1,18,"ENSG00000164078","MM909_20"
"462","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",0.0668781547860665,0.267512619144266,1,18,"ENSG00000072274","MM909_20"
"463","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.0986273786070198,0.368208880132874,1,27,"ENSG00000107295","MM909_20"
"464","TIEN_INTESTINE_PROBIOTICS_2HR_UP",0.108969519003193,0.381393316511177,1,30,"ENSG00000125691","MM909_20"
"465","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.115868804344256,0.381685473134021,3,308,"ENSG00000128595, ENSG00000112531, ENSG00000080345","MM909_20"
"466","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",0.203046429594234,0.63170000318206,1,59,"ENSG00000107882","MM909_20"
"467","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.264931346830357,0.780850285394736,1,80,"ENSG00000119414","MM909_20"
"468","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.289965713988462,0.811903999167693,1,89,"ENSG00000112531","MM909_20"
"469","MORF_PSMC2",0.357617461605942,0.953646564282512,1,115,"ENSG00000119725","MM909_20"
"470","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.480307310602043,1,1,170,"ENSG00000112531","MM909_20"
"471","MORF_PSMC1",0.51701897094736,1,1,189,"ENSG00000119414","MM909_20"
"472","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.561417024652928,1,1,214,"ENSG00000125691","MM909_20"
"473","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.632721321361238,1,2,558,"ENSG00000164045, ENSG00000239306","MM909_20"
"474","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_20"
"475","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_20"
"476","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_20"
"477","GCM_PSME1",1,1,0,83,"","MM909_20"
"478","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_20"
"479","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_20"
"480","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_20"
"481","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_20"
"482","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_20"
"483","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_20"
"484","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_20"
"485","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_20"
"486","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_20"
"487","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_20"
"488","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_20"
"489","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_20"
"490","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_20"
"491","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_20"
"492","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_20"
"493","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_20"
"494","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_20"
"495","KEGG_PROTEASOME",1,1,0,44,"","MM909_20"
"496","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_20"
"497","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_20"
"498","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_20"
"499","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_20"
"500","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_20"
"501","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_20"
"502","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_20"
"503","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_20"
"504","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_20"
"505","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.000352390141041044,0.0197338478982985,4,27,"ENSG00000136068, ENSG00000144668, ENSG00000157168, ENSG00000198959","MM909_22"
"506","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",0.00120002624457092,0.0325449537487396,4,37,"ENSG00000111885, ENSG00000134853, ENSG00000077514, ENSG00000196230","MM909_22"
"507","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.00174347966511105,0.0325449537487396,6,100,"ENSG00000039537, ENSG00000112936, ENSG00000147889, ENSG00000188037, ENSG00000160796, ENSG00000100095","MM909_22"
"508","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",0.00258781093398745,0.0362293530758243,3,22,"ENSG00000138081, ENSG00000134853, ENSG00000049769","MM909_22"
"509","MORF_PSMF1",0.0054029908632778,0.0572573636888421,7,166,"ENSG00000043039, ENSG00000166855, ENSG00000133216, ENSG00000186566, ENSG00000105737, ENSG00000078589, ENSG00000100095","MM909_22"
"510","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.00613471753809022,0.0572573636888421,7,170,"ENSG00000101474, ENSG00000241484, ENSG00000198730, ENSG00000153250, ENSG00000196628, ENSG00000104067, ENSG00000151718","MM909_22"
"511","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.0170468187470367,0.132788377954873,9,307,"ENSG00000164122, ENSG00000108094, ENSG00000138081, ENSG00000138411, ENSG00000086758, ENSG00000120696, ENSG00000159352, ENSG00000033178, ENSG00000159459","MM909_22"
"512","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.0210118488505283,0.132788377954873,6,169,"ENSG00000112936, ENSG00000048052, ENSG00000003147, ENSG00000173114, ENSG00000134853, ENSG00000139970","MM909_22"
"513","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",0.021340989314176,0.132788377954873,2,18,"ENSG00000160255, ENSG00000049769","MM909_22"
"514","GOCC_PROTEASOME_COMPLEX",0.0387836565862875,0.21718847688321,3,59,"ENSG00000159352, ENSG00000159459, ENSG00000165280","MM909_22"
"515","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.0757929975719075,0.385855260366075,2,36,"ENSG00000120885, ENSG00000115592","MM909_22"
"516","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.0833870360256395,0.389139501452984,3,81,"ENSG00000108094, ENSG00000121879, ENSG00000081237","MM909_22"
"517","MORF_PSMC1",0.0928221887366901,0.399849428404204,5,189,"ENSG00000101210, ENSG00000116199, ENSG00000140943, ENSG00000149923, ENSG00000165280","MM909_22"
"518","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",0.108149552705604,0.42000130202843,1,9,"ENSG00000159352","MM909_22"
"519","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.112500348757615,0.42000130202843,4,145,"ENSG00000128272, ENSG00000120885, ENSG00000082641, ENSG00000161011","MM909_22"
"520","WONG_PROTEASOME_GENE_MODULE",0.123169760241575,0.431094160845512,2,48,"ENSG00000161011, ENSG00000033178","MM909_22"
"521","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",0.141537850150262,0.466242329906746,1,12,"ENSG00000108094","MM909_22"
"522","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.178220926219173,0.467209665349753,5,235,"ENSG00000120885, ENSG00000128591, ENSG00000175426, ENSG00000176463, ENSG00000161011","MM909_22"
"523","MORF_PSMC2",0.178498689537274,0.467209665349753,3,115,"ENSG00000116199, ENSG00000136238, ENSG00000165280","MM909_22"
"524","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",0.184121616478353,0.467209665349753,1,16,"ENSG00000143569","MM909_22"
"525","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",0.18928598015206,0.467209665349753,2,63,"ENSG00000047932, ENSG00000159352","MM909_22"
"526","LE_SKI_TARGETS_UP",0.194433720380181,0.467209665349753,1,17,"ENSG00000157168","MM909_22"
"527","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.196727440511942,0.467209665349753,6,308,"ENSG00000136628, ENSG00000075945, ENSG00000149923, ENSG00000136238, ENSG00000143569, ENSG00000171467","MM909_22"
"528","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",0.204615645737005,0.467209665349753,1,18,"ENSG00000163362","MM909_22"
"529","GOCC_PROTEASOME_REGULATORY_PARTICLE",0.214669033898684,0.467209665349753,1,19,"ENSG00000159352","MM909_22"
"530","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.2169187731981,0.467209665349753,2,69,"ENSG00000137965, ENSG00000145687","MM909_22"
"531","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.237033930679609,0.491625930298448,3,133,"ENSG00000108094, ENSG00000086758, ENSG00000033178","MM909_22"
"532","GOCC_PROTEASOME_ACCESSORY_COMPLEX",0.253629323592125,0.50725864718425,1,23,"ENSG00000159352","MM909_22"
"533","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.268267035422373,0.515614347111264,2,80,"ENSG00000177575, ENSG00000114013","MM909_22"
"534","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.276221971666749,0.515614347111264,9,558,"ENSG00000241484, ENSG00000132361, ENSG00000108094, ENSG00000115207, ENSG00000155393, ENSG00000114988, ENSG00000153395, ENSG00000196628, ENSG00000143569","MM909_22"
"535","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.310286956496027,0.560518373025081,2,89,"ENSG00000241484, ENSG00000120885","MM909_22"
"536","KEGG_PROTEASOME",0.428631254885178,0.750104696049061,1,44,"ENSG00000159352","MM909_22"
"537","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",0.463854431007871,0.786797301345245,1,49,"ENSG00000128272","MM909_22"
"538","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.508766653745372,0.786797301345245,3,214,"ENSG00000010017, ENSG00000161011, ENSG00000170265","MM909_22"
"539","WONG_MITOCHONDRIA_GENE_MODULE",0.511875227895841,0.786797301345245,3,215,"ENSG00000131844, ENSG00000027001, ENSG00000144040","MM909_22"
"540","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",0.527927512889414,0.786797301345245,1,59,"ENSG00000159352","MM909_22"
"541","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",0.533898168769988,0.786797301345245,1,60,"ENSG00000161011","MM909_22"
"542","WP_PROTEASOME_DEGRADATION",0.533898168769988,0.786797301345245,1,60,"ENSG00000159352","MM909_22"
"543","GCM_PSME1",0.652211218373921,0.936508416126656,1,83,"ENSG00000136628","MM909_22"
"544","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_22"
"545","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_22"
"546","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_22"
"547","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_22"
"548","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_22"
"549","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_22"
"550","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_22"
"551","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_22"
"552","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_22"
"553","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_22"
"554","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_22"
"555","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_22"
"556","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_22"
"557","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_22"
"558","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_22"
"559","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_22"
"560","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_22"
"561","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.00177421456544421,0.0981823764574129,4,169,"ENSG00000048052, ENSG00000151967, ENSG00000036565, ENSG00000005379","MM909_24"
"562","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.0035065134449076,0.0981823764574129,3,100,"ENSG00000006740, ENSG00000188037, ENSG00000005108","MM909_24"
"563","GOBP_PROTEASOME_ASSEMBLY",0.0355405861673825,0.663424275124474,1,12,"ENSG00000180822","MM909_24"
"564","WONG_PROTEASOME_GENE_MODULE",0.134796759010509,1,1,48,"ENSG00000102226","MM909_24"
"565","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.158087303874957,1,2,235,"ENSG00000168918, ENSG00000137261","MM909_24"
"566","GOCC_PROTEASOME_COMPLEX",0.163047011955288,1,1,59,"ENSG00000135018","MM909_24"
"567","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.187931842185863,1,1,69,"ENSG00000086205","MM909_24"
"568","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.214455716563664,1,1,80,"ENSG00000127603","MM909_24"
"569","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.235514654860645,1,1,89,"ENSG00000126214","MM909_24"
"570","KEGG_PARKINSONS_DISEASE",0.288966028403001,1,1,113,"ENSG00000036565","MM909_24"
"571","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.501779927049276,1,2,558,"ENSG00000135316, ENSG00000102226","MM909_24"
"572","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_24"
"573","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_24"
"574","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_24"
"575","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_24"
"576","GCM_PSME1",1,1,0,83,"","MM909_24"
"577","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_24"
"578","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_24"
"579","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_24"
"580","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_24"
"581","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_24"
"582","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_24"
"583","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_24"
"584","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_24"
"585","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_24"
"586","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_24"
"587","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_24"
"588","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_24"
"589","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_24"
"590","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_24"
"591","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_24"
"592","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_24"
"593","KEGG_PROTEASOME",1,1,0,44,"","MM909_24"
"594","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_24"
"595","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_24"
"596","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_24"
"597","MORF_PSMC1",1,1,0,189,"","MM909_24"
"598","MORF_PSMC2",1,1,0,115,"","MM909_24"
"599","MORF_PSMF1",1,1,0,166,"","MM909_24"
"600","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_24"
"601","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_24"
"602","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_24"
"603","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_24"
"604","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_24"
"605","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_24"
"606","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_24"
"607","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_24"
"608","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_24"
"609","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_24"
"610","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_24"
"611","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_24"
"612","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_24"
"613","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_24"
"614","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_24"
"615","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_24"
"616","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_24"
"617","MORF_PSMF1",0.00401827611886244,0.12375509809567,3,166,"ENSG00000114923, ENSG00000152818, ENSG00000236104","MM909_25"
"618","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.00441982493198822,0.12375509809567,5,558,"ENSG00000153113, ENSG00000134057, ENSG00000141543, ENSG00000123485, ENSG00000101361","MM909_25"
"619","GCM_PSME1",0.0110559459165651,0.206377657109215,2,83,"ENSG00000067560, ENSG00000136527","MM909_25"
"620","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",0.0337136838225611,0.459772820311288,1,18,"ENSG00000074047","MM909_25"
"621","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",0.0410511446706507,0.459772820311288,1,22,"ENSG00000148498","MM909_25"
"622","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",0.0627335944367938,0.585513548076742,1,34,"ENSG00000154175","MM909_25"
"623","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.0742104145883872,0.593683316707097,2,235,"ENSG00000128918, ENSG00000204516","MM909_25"
"624","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",0.0874158871216015,0.611911209851211,1,48,"ENSG00000141510","MM909_25"
"625","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.116918666654924,0.727493925852859,2,308,"ENSG00000134057, ENSG00000135862","MM909_25"
"626","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.14307416535589,0.801215325992982,1,81,"ENSG00000204516","MM909_25"
"627","KEGG_PARKINSONS_DISEASE",0.193826959397324,0.986755429659104,1,113,"ENSG00000064692","MM909_25"
"628","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_25"
"629","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_25"
"630","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_25"
"631","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_25"
"632","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_25"
"633","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_25"
"634","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_25"
"635","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_25"
"636","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_25"
"637","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_25"
"638","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_25"
"639","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_25"
"640","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_25"
"641","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_25"
"642","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_25"
"643","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_25"
"644","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_25"
"645","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_25"
"646","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_25"
"647","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_25"
"648","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_25"
"649","KEGG_PROTEASOME",1,1,0,44,"","MM909_25"
"650","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_25"
"651","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_25"
"652","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_25"
"653","MORF_PSMC1",1,1,0,189,"","MM909_25"
"654","MORF_PSMC2",1,1,0,115,"","MM909_25"
"655","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_25"
"656","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_25"
"657","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_25"
"658","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_25"
"659","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_25"
"660","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_25"
"661","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_25"
"662","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_25"
"663","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_25"
"664","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_25"
"665","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_25"
"666","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_25"
"667","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_25"
"668","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_25"
"669","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_25"
"670","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_25"
"671","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_25"
"672","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_25"
"673","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.000241736983232738,0.0135372710610334,9,235,"ENSG00000120875, ENSG00000158560, ENSG00000083857, ENSG00000100364, ENSG00000166963, ENSG00000131711, ENSG00000059728, ENSG00000054356, ENSG00000164543","MM909_26"
"674","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.00376500979377411,0.105420274225675,3,36,"ENSG00000111206, ENSG00000168959, ENSG00000213999","MM909_26"
"675","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",0.0169004699058209,0.315475438241991,2,23,"ENSG00000112964, ENSG00000108924","MM909_26"
"676","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.0229188632777501,0.320864085888501,2,27,"ENSG00000136068, ENSG00000132970","MM909_26"
"677","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.0536096018568615,0.407094455841898,6,308,"ENSG00000152234, ENSG00000134058, ENSG00000145907, ENSG00000138448, ENSG00000075945, ENSG00000164543","MM909_26"
"678","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.0569149544453992,0.407094455841898,3,100,"ENSG00000110046, ENSG00000213999, ENSG00000168685","MM909_26"
"679","LE_SKI_TARGETS_DN",0.0592648268065066,0.407094455841898,1,7,"ENSG00000182871","MM909_26"
"680","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.0606911306085737,0.407094455841898,4,169,"ENSG00000144452, ENSG00000083123, ENSG00000149256, ENSG00000038427","MM909_26"
"681","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",0.0654258946888765,0.407094455841898,2,48,"ENSG00000110092, ENSG00000059728","MM909_26"
"682","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",0.145391146267112,0.740173108268933,1,18,"ENSG00000038427","MM909_26"
"683","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",0.145391146267112,0.740173108268933,1,18,"ENSG00000074047","MM909_26"
"684","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",0.17471876374309,0.758419086854551,1,22,"ENSG00000110092","MM909_26"
"685","MORF_PSMF1",0.176061573734092,0.758419086854551,3,166,"ENSG00000165995, ENSG00000106536, ENSG00000085433","MM909_26"
"686","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",0.256809729702585,0.961475933184486,1,34,"ENSG00000150630","MM909_26"
"687","KEGG_PARKINSONS_DISEASE",0.257538196388702,0.961475933184486,2,113,"ENSG00000152234, ENSG00000142319","MM909_26"
"688","WONG_MITOCHONDRIA_GENE_MODULE",0.287479733808891,1,3,215,"ENSG00000184047, ENSG00000172500, ENSG00000114054","MM909_26"
"689","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.357255571163754,1,6,558,"ENSG00000183044, ENSG00000110092, ENSG00000100243, ENSG00000111206, ENSG00000145907, ENSG00000196628","MM909_26"
"690","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",0.407779996307702,1,1,60,"ENSG00000101680","MM909_26"
"691","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",0.423098581035592,1,1,63,"ENSG00000181789","MM909_26"
"692","MORF_PSMC1",0.489805128480849,1,2,189,"ENSG00000134058, ENSG00000100926","MM909_26"
"693","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.502725122583939,1,1,80,"ENSG00000134058","MM909_26"
"694","GCM_PSME1",0.515591804279738,1,1,83,"ENSG00000138668","MM909_26"
"695","MORF_PSMC2",0.633783642173317,1,1,115,"ENSG00000145907","MM909_26"
"696","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.718291028601845,1,1,145,"ENSG00000139793","MM909_26"
"697","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.747486938404305,1,2,307,"ENSG00000183580, ENSG00000063978","MM909_26"
"698","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.773633521138731,1,1,170,"ENSG00000196628","MM909_26"
"699","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.845992596732695,1,1,214,"ENSG00000139793","MM909_26"
"700","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_26"
"701","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_26"
"702","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_26"
"703","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_26"
"704","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_26"
"705","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_26"
"706","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_26"
"707","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_26"
"708","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_26"
"709","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_26"
"710","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_26"
"711","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_26"
"712","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_26"
"713","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_26"
"714","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_26"
"715","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_26"
"716","KEGG_PROTEASOME",1,1,0,44,"","MM909_26"
"717","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_26"
"718","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_26"
"719","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_26"
"720","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_26"
"721","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_26"
"722","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_26"
"723","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_26"
"724","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_26"
"725","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_26"
"726","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_26"
"727","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_26"
"728","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_26"
"729","MORF_PSMF1",5.43013480109567e-06,0.000304087548861357,4,166,"ENSG00000170004, ENSG00000091831, ENSG00000243156, ENSG00000162896","MM909_27"
"730","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.0244226752564042,0.683834907179317,1,36,"ENSG00000091831","MM909_27"
"731","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.0541324465532719,0.929731626038839,1,81,"ENSG00000165119","MM909_27"
"732","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.0664094018599171,0.929731626038839,1,100,"ENSG00000104921","MM909_27"
"733","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.109698254895812,1,1,169,"ENSG00000151967","MM909_27"
"734","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.190472012389732,1,1,307,"ENSG00000134900","MM909_27"
"735","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_27"
"736","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_27"
"737","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_27"
"738","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_27"
"739","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_27"
"740","GCM_PSME1",1,1,0,83,"","MM909_27"
"741","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_27"
"742","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_27"
"743","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_27"
"744","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_27"
"745","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_27"
"746","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_27"
"747","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_27"
"748","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_27"
"749","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_27"
"750","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_27"
"751","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_27"
"752","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_27"
"753","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_27"
"754","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_27"
"755","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_27"
"756","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_27"
"757","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_27"
"758","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_27"
"759","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_27"
"760","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_27"
"761","KEGG_PROTEASOME",1,1,0,44,"","MM909_27"
"762","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_27"
"763","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_27"
"764","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_27"
"765","MORF_PSMC1",1,1,0,189,"","MM909_27"
"766","MORF_PSMC2",1,1,0,115,"","MM909_27"
"767","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_27"
"768","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_27"
"769","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_27"
"770","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_27"
"771","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_27"
"772","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_27"
"773","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_27"
"774","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_27"
"775","TIEN_INTESTINE_PROBIOTICS_24HR_UP",1,1,0,558,"","MM909_27"
"776","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_27"
"777","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_27"
"778","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_27"
"779","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_27"
"780","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_27"
"781","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_27"
"782","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_27"
"783","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_27"
"784","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_27"
"785","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",8.70692471068785e-06,0.00048758778379852,4,80,"ENSG00000111605, ENSG00000159023, ENSG00000100442, ENSG00000127603","MM909_31"
"786","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.00748505090821249,0.20958142542995,2,81,"ENSG00000118217, ENSG00000150995","MM909_31"
"787","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.0131787630854358,0.246003577594802,3,307,"ENSG00000116514, ENSG00000204599, ENSG00000109906","MM909_31"
"788","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.0459582250279042,0.520163062152794,2,214,"ENSG00000106070, ENSG00000116514","MM909_31"
"789","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.0542776133303301,0.520163062152794,2,235,"ENSG00000120885, ENSG00000159023","MM909_31"
"790","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.0557317566592279,0.520163062152794,1,36,"ENSG00000120885","MM909_31"
"791","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",0.0897162950688484,0.717730360550787,1,59,"ENSG00000142875","MM909_31"
"792","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.132229751822992,0.925608262760947,1,89,"ENSG00000120885","MM909_31"
"793","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.20639526014831,1,1,145,"ENSG00000120885","MM909_31"
"794","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.222874801779923,1,2,558,"ENSG00000111605, ENSG00000100442","MM909_31"
"795","WONG_MITOCHONDRIA_GENE_MODULE",0.290331083580796,1,1,215,"ENSG00000016391","MM909_31"
"796","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_31"
"797","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_31"
"798","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_31"
"799","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_31"
"800","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_31"
"801","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_31"
"802","GCM_PSME1",1,1,0,83,"","MM909_31"
"803","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_31"
"804","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_31"
"805","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_31"
"806","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_31"
"807","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_31"
"808","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_31"
"809","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_31"
"810","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_31"
"811","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_31"
"812","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_31"
"813","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_31"
"814","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_31"
"815","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_31"
"816","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_31"
"817","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_31"
"818","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_31"
"819","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_31"
"820","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_31"
"821","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_31"
"822","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_31"
"823","KEGG_PROTEASOME",1,1,0,44,"","MM909_31"
"824","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_31"
"825","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_31"
"826","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_31"
"827","MORF_PSMC1",1,1,0,189,"","MM909_31"
"828","MORF_PSMC2",1,1,0,115,"","MM909_31"
"829","MORF_PSMF1",1,1,0,166,"","MM909_31"
"830","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_31"
"831","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_31"
"832","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_31"
"833","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_31"
"834","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_31"
"835","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_31"
"836","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_31"
"837","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_31"
"838","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_31"
"839","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_31"
"840","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_31"
"841","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.0099147505786401,0.250498936619993,2,145,"ENSG00000159256, ENSG00000186462","MM909_34"
"842","MORF_PSMF1",0.0128273891872783,0.250498936619993,2,166,"ENSG00000104884, ENSG00000157106","MM909_34"
"843","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.0134195858903568,0.250498936619993,2,170,"ENSG00000164093, ENSG00000108395","MM909_34"
"844","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.0274360145925147,0.384104204295205,1,27,"ENSG00000186111","MM909_34"
"845","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.0686474279498264,0.768851193038055,1,69,"ENSG00000136928","MM909_34"
"846","MORF_PSMC2",0.111811745576313,1,1,115,"ENSG00000160710","MM909_34"
"847","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.128160457244128,1,1,133,"ENSG00000108395","MM909_34"
"848","MORF_PSMC1",0.177151003191973,1,1,189,"ENSG00000160710","MM909_34"
"849","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.198136680708489,1,1,214,"ENSG00000090861","MM909_34"
"850","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.215356605279389,1,1,235,"ENSG00000157106","MM909_34"
"851","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.271676865377672,1,1,307,"ENSG00000108395","MM909_34"
"852","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.438605312349574,1,1,558,"ENSG00000160710","MM909_34"
"853","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_34"
"854","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_34"
"855","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_34"
"856","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_34"
"857","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_34"
"858","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_34"
"859","GCM_PSME1",1,1,0,83,"","MM909_34"
"860","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_34"
"861","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_34"
"862","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_34"
"863","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_34"
"864","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_34"
"865","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_34"
"866","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_34"
"867","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_34"
"868","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_34"
"869","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_34"
"870","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_34"
"871","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_34"
"872","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_34"
"873","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_34"
"874","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_34"
"875","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_34"
"876","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_34"
"877","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_34"
"878","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_34"
"879","KEGG_PROTEASOME",1,1,0,44,"","MM909_34"
"880","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_34"
"881","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_34"
"882","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_34"
"883","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_34"
"884","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_34"
"885","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_34"
"886","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_34"
"887","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_34"
"888","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_34"
"889","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_34"
"890","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_34"
"891","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_34"
"892","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_34"
"893","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_34"
"894","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_34"
"895","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_34"
"896","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_34"
"897","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1.48727243145068e-06,8.32872561612381e-05,4,69,"ENSG00000006016, ENSG00000140443, ENSG00000074527, ENSG00000107165","MM909_35"
"898","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",0.0257654397220899,0.468376927010988,1,22,"ENSG00000043462","MM909_35"
"899","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",0.0269208989383993,0.468376927010988,1,23,"ENSG00000107165","MM909_35"
"900","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",0.0395420356609828,0.468376927010988,1,34,"ENSG00000150630","MM909_35"
"901","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",0.041819368483124,0.468376927010988,1,36,"ENSG00000140443","MM909_35"
"902","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",0.0564926888044357,0.504327476522128,1,49,"ENSG00000093183","MM909_35"
"903","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",0.068735208624303,0.504327476522128,1,60,"ENSG00000107165","MM909_35"
"904","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",0.0720467823603039,0.504327476522128,1,63,"ENSG00000131871","MM909_35"
"905","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.111946366637753,0.696555170190462,1,100,"ENSG00000106351","MM909_35"
"906","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.141982832393321,0.795103861402599,2,558,"ENSG00000186815, ENSG00000116830","MM909_35"
"907","MORF_PSMF1",0.178958917923878,0.911063582157926,1,166,"ENSG00000085433","MM909_35"
"908","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_35"
"909","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_35"
"910","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_35"
"911","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_35"
"912","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_35"
"913","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_35"
"914","GCM_PSME1",1,1,0,83,"","MM909_35"
"915","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_35"
"916","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_35"
"917","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_35"
"918","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_35"
"919","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_35"
"920","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_35"
"921","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_35"
"922","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_35"
"923","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_35"
"924","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_35"
"925","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_35"
"926","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_35"
"927","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_35"
"928","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_35"
"929","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_35"
"930","KEGG_PROTEASOME",1,1,0,44,"","MM909_35"
"931","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_35"
"932","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_35"
"933","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_35"
"934","MORF_PSMC1",1,1,0,189,"","MM909_35"
"935","MORF_PSMC2",1,1,0,115,"","MM909_35"
"936","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_35"
"937","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_35"
"938","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_35"
"939","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_35"
"940","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_35"
"941","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_35"
"942","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_35"
"943","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_35"
"944","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_35"
"945","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_35"
"946","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_35"
"947","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_35"
"948","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_35"
"949","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_35"
"950","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_35"
"951","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_35"
"952","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_35"
"953","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.00349094040473008,0.135133119556365,3,558,"ENSG00000176102, ENSG00000112984, ENSG00000150687","MM909_36"
"954","MORF_PSMC1",0.00482618284129874,0.135133119556365,2,189,"ENSG00000107959, ENSG00000119414","MM909_36"
"955","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",0.020010452418194,0.373528445139621,1,37,"ENSG00000117114","MM909_36"
"956","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",0.032252748074711,0.399255322108968,1,60,"ENSG00000150687","MM909_36"
"957","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.0370026589310328,0.399255322108968,1,69,"ENSG00000150687","MM909_36"
"958","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.0427773559402466,0.399255322108968,1,80,"ENSG00000119414","MM909_36"
"959","MORF_PSMF1",0.0867800025259575,0.69424002020766,1,166,"ENSG00000176102","MM909_36"
"960","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_36"
"961","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_36"
"962","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_36"
"963","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_36"
"964","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_36"
"965","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_36"
"966","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_36"
"967","GCM_PSME1",1,1,0,83,"","MM909_36"
"968","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_36"
"969","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_36"
"970","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_36"
"971","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_36"
"972","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_36"
"973","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_36"
"974","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_36"
"975","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_36"
"976","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_36"
"977","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_36"
"978","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_36"
"979","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_36"
"980","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_36"
"981","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_36"
"982","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_36"
"983","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_36"
"984","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_36"
"985","KEGG_PROTEASOME",1,1,0,44,"","MM909_36"
"986","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_36"
"987","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_36"
"988","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_36"
"989","MORF_PSMC2",1,1,0,115,"","MM909_36"
"990","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_36"
"991","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_36"
"992","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_36"
"993","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_36"
"994","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_36"
"995","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_36"
"996","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_36"
"997","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_36"
"998","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_36"
"999","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_36"
"1000","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_36"
"1001","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_36"
"1002","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_36"
"1003","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_36"
"1004","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_36"
"1005","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_36"
"1006","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_36"
"1007","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_36"
"1008","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_36"
"1009","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",0.000769367890973009,0.0430846018944885,2,49,"ENSG00000099341, ENSG00000204267","MM909_37"
"1010","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",0.00577358442346432,0.121196208379157,1,7,"ENSG00000099341","MM909_37"
"1011","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.00649265402031197,0.121196208379157,2,145,"ENSG00000106105, ENSG00000140678","MM909_37"
"1012","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.0136691835433631,0.174665794265428,2,214,"ENSG00000106105, ENSG00000073417","MM909_37"
"1013","GOCC_PROTEASOME_REGULATORY_PARTICLE",0.0155951602022704,0.174665794265428,1,19,"ENSG00000099341","MM909_37"
"1014","GOCC_PROTEASOME_ACCESSORY_COMPLEX",0.0188478159869757,0.175912949211773,1,23,"ENSG00000099341","MM909_37"
"1015","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.0269955631779428,0.215964505423543,2,308,"ENSG00000106105, ENSG00000099341","MM909_37"
"1016","KEGG_PROTEASOME",0.0357520281936264,0.218830267145083,1,44,"ENSG00000099341","MM909_37"
"1017","WONG_PROTEASOME_GENE_MODULE",0.0389393238669087,0.218830267145083,1,48,"ENSG00000099341","MM909_37"
"1018","GOCC_PROTEASOME_COMPLEX",0.047651183698446,0.218830267145083,1,59,"ENSG00000099341","MM909_37"
"1019","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",0.047651183698446,0.218830267145083,1,59,"ENSG00000099341","MM909_37"
"1020","WP_PROTEASOME_DEGRADATION",0.0484393180341889,0.218830267145083,1,60,"ENSG00000099341","MM909_37"
"1021","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",0.0507998834443942,0.218830267145083,1,63,"ENSG00000105254","MM909_37"
"1022","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.0648430950524184,0.259372380209673,1,81,"ENSG00000162434","MM909_37"
"1023","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.079445333865366,0.296595913097366,1,100,"ENSG00000204267","MM909_37"
"1024","MORF_PSMF1",0.128451593992246,0.43264270565492,1,166,"ENSG00000171862","MM909_37"
"1025","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.131337964216672,0.43264270565492,1,170,"ENSG00000077044","MM909_37"
"1026","MORF_PSMC1",0.144920646871047,0.450864234709923,1,189,"ENSG00000099341","MM909_37"
"1027","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.224729372679251,0.662360256317791,1,307,"ENSG00000099341","MM909_37"
"1028","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_37"
"1029","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_37"
"1030","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_37"
"1031","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_37"
"1032","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_37"
"1033","GCM_PSME1",1,1,0,83,"","MM909_37"
"1034","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_37"
"1035","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_37"
"1036","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_37"
"1037","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_37"
"1038","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_37"
"1039","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_37"
"1040","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_37"
"1041","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_37"
"1042","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_37"
"1043","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_37"
"1044","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_37"
"1045","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_37"
"1046","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_37"
"1047","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_37"
"1048","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_37"
"1049","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_37"
"1050","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_37"
"1051","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_37"
"1052","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_37"
"1053","MORF_PSMC2",1,1,0,115,"","MM909_37"
"1054","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_37"
"1055","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_37"
"1056","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_37"
"1057","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_37"
"1058","TIEN_INTESTINE_PROBIOTICS_24HR_UP",1,1,0,558,"","MM909_37"
"1059","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_37"
"1060","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_37"
"1061","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_37"
"1062","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_37"
"1063","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_37"
"1064","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_37"
"1065","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",0.000241314879255434,0.0135136332383043,2,16,"ENSG00000115414, ENSG00000242265","MM909_40"
"1066","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",0.0022931449998898,0.0642080599969144,2,49,"ENSG00000164307, ENSG00000205220","MM909_40"
"1067","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.0048050529306593,0.089694321372307,3,235,"ENSG00000105993, ENSG00000173706, ENSG00000144747","MM909_40"
"1068","GOCC_SPERMATOPROTEASOME_COMPLEX",0.00715571696119199,0.100180037456688,1,5,"ENSG00000205220","MM909_40"
"1069","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.0099806694664483,0.111783498024221,3,307,"ENSG00000205220, ENSG00000131263, ENSG00000164068","MM909_40"
"1070","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",0.0142607822635308,0.133100634459621,1,10,"ENSG00000205220","MM909_40"
"1071","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",0.0227204995753274,0.167523303247022,1,16,"ENSG00000163466","MM909_40"
"1072","MORF_PSMF1",0.0239627458343812,0.167523303247022,2,166,"ENSG00000142675, ENSG00000174197","MM909_40"
"1073","GOCC_PROTEASOME_CORE_COMPLEX",0.0269233880218428,0.167523303247022,1,19,"ENSG00000205220","MM909_40"
"1074","KEGG_PROTEASOME",0.0612592561448063,0.289108432496172,1,44,"ENSG00000205220","MM909_40"
"1075","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",0.0666406471421489,0.289108432496172,1,48,"ENSG00000242265","MM909_40"
"1076","WONG_PROTEASOME_GENE_MODULE",0.0666406471421489,0.289108432496172,1,48,"ENSG00000205220","MM909_40"
"1077","GOCC_PROTEASOME_COMPLEX",0.0812826397994552,0.289108432496172,1,59,"ENSG00000205220","MM909_40"
"1078","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",0.0812826397994552,0.289108432496172,1,59,"ENSG00000205220","MM909_40"
"1079","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",0.0826024092846206,0.289108432496172,1,60,"ENSG00000101680","MM909_40"
"1080","WP_PROTEASOME_DEGRADATION",0.0826024092846206,0.289108432496172,1,60,"ENSG00000205220","MM909_40"
"1081","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.188190642304085,0.619922115825221,1,145,"ENSG00000115956","MM909_40"
"1082","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.215763005109638,0.671262682563318,1,169,"ENSG00000148773","MM909_40"
"1083","MORF_PSMC1",0.238030808300513,0.701564487622564,1,189,"ENSG00000168385","MM909_40"
"1084","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.552880168383657,1,1,558,"ENSG00000173706","MM909_40"
"1085","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_40"
"1086","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_40"
"1087","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_40"
"1088","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_40"
"1089","GCM_PSME1",1,1,0,83,"","MM909_40"
"1090","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_40"
"1091","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_40"
"1092","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_40"
"1093","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_40"
"1094","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_40"
"1095","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_40"
"1096","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_40"
"1097","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_40"
"1098","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_40"
"1099","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_40"
"1100","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_40"
"1101","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_40"
"1102","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_40"
"1103","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_40"
"1104","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_40"
"1105","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",1,1,0,133,"","MM909_40"
"1106","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_40"
"1107","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_40"
"1108","MORF_PSMC2",1,1,0,115,"","MM909_40"
"1109","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_40"
"1110","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_40"
"1111","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_40"
"1112","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_40"
"1113","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_40"
"1114","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_40"
"1115","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_40"
"1116","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_40"
"1117","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_40"
"1118","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_40"
"1119","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_40"
"1120","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_40"
"1121","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",9.11322952384206e-07,5.10340853335155e-05,8,169,"ENSG00000087586, ENSG00000140937, ENSG00000126787, ENSG00000138080, ENSG00000196482, ENSG00000048052, ENSG00000156113, ENSG00000148773","MM909_42"
"1122","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",0.00100535324152552,0.0281498907627145,4,100,"ENSG00000166743, ENSG00000188037, ENSG00000069020, ENSG00000122121","MM909_42"
"1123","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",0.00414545365652214,0.0773818015884132,2,22,"ENSG00000175899, ENSG00000090621","MM909_42"
"1124","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.00710041314402928,0.09940578401641,3,89,"ENSG00000073756, ENSG00000174718, ENSG00000115904","MM909_42"
"1125","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",0.0114485964716543,0.128224280482528,2,37,"ENSG00000042493, ENSG00000140937","MM909_42"
"1126","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",0.0284972552138307,0.22971778960941,2,60,"ENSG00000101680, ENSG00000105281","MM909_42"
"1127","BIOCARTA_RARRXR_PATHWAY",0.0301798923257909,0.22971778960941,1,7,"ENSG00000084676","MM909_42"
"1128","MORF_PSMF1",0.0367001691761748,0.22971778960941,3,166,"ENSG00000106536, ENSG00000170190, ENSG00000122779","MM909_42"
"1129","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.0369189304729409,0.22971778960941,6,558,"ENSG00000087586, ENSG00000110442, ENSG00000126787, ENSG00000149218, ENSG00000141429, ENSG00000085511","MM909_42"
"1130","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.0679940886281243,0.353649679972324,3,214,"ENSG00000156650, ENSG00000105281, ENSG00000052841","MM909_42"
"1131","LE_SKI_TARGETS_UP",0.0717262633056964,0.353649679972324,1,17,"ENSG00000140937","MM909_42"
"1132","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",0.0757820742797838,0.353649679972324,1,18,"ENSG00000175899","MM909_42"
"1133","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.111498902846908,0.480302966109759,1,27,"ENSG00000161021","MM909_42"
"1134","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.151712520459268,0.606850081837072,3,307,"ENSG00000108306, ENSG00000003096, ENSG00000146021","MM909_42"
"1135","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.170404890164724,0.636178256614971,2,170,"ENSG00000077044, ENSG00000085511","MM909_42"
"1136","WONG_PROTEASOME_GENE_MODULE",0.189579748438849,0.659444248898545,1,48,"ENSG00000155313","MM909_42"
"1137","MORF_PSMC1",0.200188432701344,0.659444248898545,2,189,"ENSG00000121058, ENSG00000102974","MM909_42"
"1138","WONG_MITOCHONDRIA_GENE_MODULE",0.241771595914489,0.752178298400631,2,215,"ENSG00000131828, ENSG00000170190","MM909_42"
"1139","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.274020122894899,0.807638256953387,2,235,"ENSG00000151320, ENSG00000184205","MM909_42"
"1140","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.389712022693516,1,2,308,"ENSG00000205339, ENSG00000090060","MM909_42"
"1141","MORF_PSMC2",0.395814421130762,1,1,115,"ENSG00000121058","MM909_42"
"1142","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.441680125455056,1,1,133,"ENSG00000003096","MM909_42"
"1143","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_42"
"1144","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_42"
"1145","GCM_PSME1",1,1,0,83,"","MM909_42"
"1146","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_42"
"1147","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_42"
"1148","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_42"
"1149","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_42"
"1150","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_42"
"1151","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_42"
"1152","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_42"
"1153","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_42"
"1154","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_42"
"1155","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_42"
"1156","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_42"
"1157","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_42"
"1158","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_42"
"1159","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_42"
"1160","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_42"
"1161","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_42"
"1162","KEGG_PROTEASOME",1,1,0,44,"","MM909_42"
"1163","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_42"
"1164","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_42"
"1165","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_42"
"1166","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_42"
"1167","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_42"
"1168","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_42"
"1169","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_42"
"1170","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_42"
"1171","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_42"
"1172","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_42"
"1173","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_42"
"1174","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_42"
"1175","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_42"
"1176","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_42"
"1177","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.00890870851138082,0.347876709190329,5,307,"ENSG00000114423, ENSG00000109670, ENSG00000131263, ENSG00000173821, ENSG00000175093","MM909_43"
"1178","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",0.0219618707802808,0.347876709190329,3,145,"ENSG00000115165, ENSG00000186462, ENSG00000087842","MM909_43"
"1179","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",0.0242751318336094,0.347876709190329,1,6,"ENSG00000100644","MM909_43"
"1180","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",0.0275986041539825,0.347876709190329,2,63,"ENSG00000181789, ENSG00000112812","MM909_43"
"1181","MORF_PSMF1",0.0310604204634222,0.347876709190329,3,166,"ENSG00000085224, ENSG00000170004, ENSG00000100578","MM909_43"
"1182","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",0.0426915382668244,0.349256503461238,2,80,"ENSG00000177575, ENSG00000119414","MM909_43"
"1183","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.0436570629326548,0.349256503461238,2,81,"ENSG00000100644, ENSG00000186432","MM909_43"
"1184","KEGG_PARKINSONS_DISEASE",0.0784048832912366,0.548834183038656,2,113,"ENSG00000142319, ENSG00000140740","MM909_43"
"1185","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.103255799583238,0.586357947062038,2,133,"ENSG00000114423, ENSG00000109670","MM909_43"
"1186","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.104706776261078,0.586357947062038,1,27,"ENSG00000136068","MM909_43"
"1187","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.152229715864615,0.774987644401678,2,169,"ENSG00000237649, ENSG00000138119","MM909_43"
"1188","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",0.178531435385253,0.783532560581551,1,48,"ENSG00000100644","MM909_43"
"1189","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",0.18189148727786,0.783532560581551,1,49,"ENSG00000234745","MM909_43"
"1190","WP_PROTEASOME_DEGRADATION",0.217960543651391,0.871842174605562,1,60,"ENSG00000234745","MM909_43"
"1191","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",0.246289926064337,0.873787833601257,1,69,"ENSG00000086205","MM909_43"
"1192","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.249653666743216,0.873787833601257,2,235,"ENSG00000160712, ENSG00000085831","MM909_43"
"1193","TIEN_INTESTINE_PROBIOTICS_2HR_DN",0.305636981371548,1,1,89,"ENSG00000071054","MM909_43"
"1194","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.399304778806746,1,3,558,"ENSG00000104341, ENSG00000071054, ENSG00000133131","MM909_43"
"1195","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.502010000163497,1,1,170,"ENSG00000129657","MM909_43"
"1196","MORF_PSMC1",0.539393074728881,1,1,189,"ENSG00000119414","MM909_43"
"1197","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.717615306514951,1,1,308,"ENSG00000101367","MM909_43"
"1198","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_43"
"1199","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_43"
"1200","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_43"
"1201","GCM_PSME1",1,1,0,83,"","MM909_43"
"1202","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_43"
"1203","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_43"
"1204","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_43"
"1205","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_43"
"1206","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_43"
"1207","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_43"
"1208","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_43"
"1209","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_43"
"1210","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_43"
"1211","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_43"
"1212","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_43"
"1213","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_43"
"1214","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_43"
"1215","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_43"
"1216","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_43"
"1217","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_43"
"1218","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_43"
"1219","KEGG_PROTEASOME",1,1,0,44,"","MM909_43"
"1220","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_43"
"1221","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_43"
"1222","MORF_PSMC2",1,1,0,115,"","MM909_43"
"1223","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_43"
"1224","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_43"
"1225","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_43"
"1226","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_43"
"1227","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_43"
"1228","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_43"
"1229","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_43"
"1230","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_43"
"1231","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_43"
"1232","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_43"
"1233","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",0.00201548682015317,0.0743120894731744,3,81,"ENSG00000204252, ENSG00000135486, ENSG00000137462","MM909_46"
"1234","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",0.00265400319547051,0.0743120894731744,5,307,"ENSG00000198881, ENSG00000094880, ENSG00000108306, ENSG00000049759, ENSG00000153827","MM909_46"
"1235","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.00806444915990436,0.150536384318215,3,133,"ENSG00000094880, ENSG00000049759, ENSG00000153827","MM909_46"
"1236","MORF_PSMF1",0.0146419128253359,0.204986779554702,3,166,"ENSG00000134769, ENSG00000133216, ENSG00000105171","MM909_46"
"1237","LE_SKI_TARGETS_DN",0.0212090385947358,0.22674656721047,1,7,"ENSG00000105825","MM909_46"
"1238","GCM_PSME1",0.0269191367261184,0.22674656721047,2,83,"ENSG00000135486, ENSG00000126457","MM909_46"
"1239","TIEN_INTESTINE_PROBIOTICS_24HR_DN",0.0283433209013087,0.22674656721047,3,214,"ENSG00000188554, ENSG00000133321, ENSG00000068323","MM909_46"
"1240","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",0.0478214586993957,0.33475021089577,1,16,"ENSG00000155093","MM909_46"
"1241","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",0.0793719653194455,0.493870006432105,1,27,"ENSG00000144668","MM909_46"
"1242","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",0.107150624075223,0.581698318785441,1,37,"ENSG00000117114","MM909_46"
"1243","MORF_PSMC1",0.114262169761426,0.581698318785441,2,189,"ENSG00000140943, ENSG00000126457","MM909_46"
"1244","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",0.242736085004633,1,2,308,"ENSG00000086504, ENSG00000198033","MM909_46"
"1245","MORF_PSMC2",0.297057208350306,1,1,115,"ENSG00000126457","MM909_46"
"1246","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",0.404414885380434,1,1,169,"ENSG00000144452","MM909_46"
"1247","TIEN_INTESTINE_PROBIOTICS_6HR_DN",0.406240776273485,1,1,170,"ENSG00000182621","MM909_46"
"1248","WONG_MITOCHONDRIA_GENE_MODULE",0.482890185742452,1,1,215,"ENSG00000196329","MM909_46"
"1249","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",0.51371568904613,1,1,235,"ENSG00000134769","MM909_46"
"1250","TIEN_INTESTINE_PROBIOTICS_24HR_UP",0.820260799073864,1,1,558,"ENSG00000182621","MM909_46"
"1251","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_46"
"1252","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_46"
"1253","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_46"
"1254","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_46"
"1255","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_46"
"1256","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_46"
"1257","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_46"
"1258","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_46"
"1259","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_46"
"1260","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_46"
"1261","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_46"
"1262","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_46"
"1263","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_46"
"1264","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_46"
"1265","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_46"
"1266","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_46"
"1267","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_46"
"1268","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_46"
"1269","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_46"
"1270","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_46"
"1271","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_46"
"1272","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_46"
"1273","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_46"
"1274","KEGG_PROTEASOME",1,1,0,44,"","MM909_46"
"1275","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_46"
"1276","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_46"
"1277","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_46"
"1278","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_46"
"1279","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_46"
"1280","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_46"
"1281","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_46"
"1282","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_46"
"1283","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_46"
"1284","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_46"
"1285","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_46"
"1286","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_46"
"1287","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_46"
"1288","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_46"
"1289","KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS",0.0246177417325838,1,1,133,"ENSG00000105229","MM909_47"
"1290","BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE",1,1,0,48,"","MM909_47"
"1291","BIOCARTA_PROTEASOME_PATHWAY",1,1,0,18,"","MM909_47"
"1292","BIOCARTA_RARRXR_PATHWAY",1,1,0,7,"","MM909_47"
"1293","BORCZUK_MALIGNANT_MESOTHELIOMA_DN",1,1,0,100,"","MM909_47"
"1294","BORCZUK_MALIGNANT_MESOTHELIOMA_UP",1,1,0,308,"","MM909_47"
"1295","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN",1,1,0,169,"","MM909_47"
"1296","CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP",1,1,0,235,"","MM909_47"
"1297","GCM_PSME1",1,1,0,83,"","MM909_47"
"1298","GOBP_PROTEASOME_ASSEMBLY",1,1,0,12,"","MM909_47"
"1299","GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY",1,1,0,12,"","MM909_47"
"1300","GOCC_PROTEASOME_ACCESSORY_COMPLEX",1,1,0,23,"","MM909_47"
"1301","GOCC_PROTEASOME_COMPLEX",1,1,0,59,"","MM909_47"
"1302","GOCC_PROTEASOME_CORE_COMPLEX",1,1,0,19,"","MM909_47"
"1303","GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX",1,1,0,8,"","MM909_47"
"1304","GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX",1,1,0,10,"","MM909_47"
"1305","GOCC_PROTEASOME_REGULATORY_PARTICLE",1,1,0,19,"","MM909_47"
"1306","GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX",1,1,0,9,"","MM909_47"
"1307","GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX",1,1,0,7,"","MM909_47"
"1308","GOCC_SPERMATOPROTEASOME_COMPLEX",1,1,0,5,"","MM909_47"
"1309","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN",1,1,0,22,"","MM909_47"
"1310","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP",1,1,0,69,"","MM909_47"
"1311","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN",1,1,0,6,"","MM909_47"
"1312","HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP",1,1,0,23,"","MM909_47"
"1313","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN",1,1,0,37,"","MM909_47"
"1314","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP",1,1,0,34,"","MM909_47"
"1315","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN",1,1,0,18,"","MM909_47"
"1316","HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP",1,1,0,60,"","MM909_47"
"1317","KEGG_PARKINSONS_DISEASE",1,1,0,113,"","MM909_47"
"1318","KEGG_PROTEASOME",1,1,0,44,"","MM909_47"
"1319","LE_SKI_TARGETS_DN",1,1,0,7,"","MM909_47"
"1320","LE_SKI_TARGETS_UP",1,1,0,17,"","MM909_47"
"1321","MORF_PSMC1",1,1,0,189,"","MM909_47"
"1322","MORF_PSMC2",1,1,0,115,"","MM909_47"
"1323","MORF_PSMF1",1,1,0,166,"","MM909_47"
"1324","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN",1,1,0,49,"","MM909_47"
"1325","PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP",1,1,0,63,"","MM909_47"
"1326","PODAR_RESPONSE_TO_ADAPHOSTIN_DN",1,1,0,18,"","MM909_47"
"1327","PODAR_RESPONSE_TO_ADAPHOSTIN_UP",1,1,0,145,"","MM909_47"
"1328","REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION",1,1,0,307,"","MM909_47"
"1329","REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME",1,1,0,59,"","MM909_47"
"1330","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN",1,1,0,36,"","MM909_47"
"1331","SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP",1,1,0,81,"","MM909_47"
"1332","SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN",1,1,0,80,"","MM909_47"
"1333","SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP",1,1,0,27,"","MM909_47"
"1334","TIEN_INTESTINE_PROBIOTICS_24HR_DN",1,1,0,214,"","MM909_47"
"1335","TIEN_INTESTINE_PROBIOTICS_24HR_UP",1,1,0,558,"","MM909_47"
"1336","TIEN_INTESTINE_PROBIOTICS_2HR_DN",1,1,0,89,"","MM909_47"
"1337","TIEN_INTESTINE_PROBIOTICS_2HR_UP",1,1,0,30,"","MM909_47"
"1338","TIEN_INTESTINE_PROBIOTICS_6HR_DN",1,1,0,170,"","MM909_47"
"1339","TIEN_INTESTINE_PROBIOTICS_6HR_UP",1,1,0,52,"","MM909_47"
"1340","VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN",1,1,0,16,"","MM909_47"
"1341","VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP",1,1,0,16,"","MM909_47"
"1342","WONG_MITOCHONDRIA_GENE_MODULE",1,1,0,215,"","MM909_47"
"1343","WONG_PROTEASOME_GENE_MODULE",1,1,0,48,"","MM909_47"
"1344","WP_PROTEASOME_DEGRADATION",1,1,0,60,"","MM909_47"
